Contribute Try STAT+ Today

Hello, everyone, and how are you today? We are doing reasonably well, given the circumstances. A warm sun and rising humidity are starting to envelope the Pharmalot campus, where the short person is sleeping in and the official mascot is bounding about. As for us, we are busy compiling our to-do list and brewing another cup of stimulation. Meanwhile, here is the latest list of interesting items to help you get organized yourself. We hope today is productive and meaningful. And as always, stay safe. …

A White House meeting with top pharmaceutical executives that President Trump promised for Tuesday is off, Politico writes. The discussion on drug pricing was cancelled because the major drug lobbies, reeling from a cluster of executive orders issued late Friday on the topic, refused to send any members. Drug makers and Trump were slated to discuss one executive order, signed Friday but not yet released, that would order health officials to release a plan linking Medicare payments for certain medicines to lower costs paid abroad.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Your daily dose of news in health and medicine

Privacy Policy